NEW YORK (GenomeWeb News) – Tokyo-based Chugai Pharmaceutical has signed a multi-year license agreement with Genedata for the use of its biomarker discovery software in R&D programs, the Swiss bioinformatics company said today.

Genedata said that Chugai has already been using the Expressionist software to normalize its microarray data pool, to standardize its microarray quality control process, and to obtain data for analysis.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.